Tailored hormonal approach in women with premature ovarian insufficiency
review
OA: closed
CC0
AI-generated summary
This review proposes an integrated, patient-based hormonal approach for women with premature ovarian insufficiency, addressing fertility, symptoms, and long-term health from puberty to late reproductive age.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Premature ovarian insufficiency (POI) is probably one of the most devastating diagnoses for women of reproductive age. The major implications for fertility, climacteric symptoms, and quality of life, the great impact of long-term consequences such as bone loss and cardiovascular health, and the lack of a coherent and shared clinical approach make the choice for the right hormonal therapy challenging. In this review we propose an integrated and patient-based hormonal approach for women with POI, from puberty to late reproductive age.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Cardiovascular Effects of Physiological and Standard Sex Steroid Replacement Regimens in Premature Ovarian Failure 2009
- Hormone Replacement Therapy Versus the Combined Oral Contraceptive Pill in Premature Ovarian Failure: A Randomized Controlled Trial of the Effects on Bone Mineral Density 2016
- Physiological sex steroid replacement in premature ovarian failure: randomized crossover trial of effect on uterine volume, endometrial thickness and blood flow, compared with a standard regimen 2012
References (60)
- Cardiovascular Effects of Physiological and Standard Sex Steroid Replacement Regimens in Premature Ovarian Failure via openalex
- Hormone Replacement Therapy Versus the Combined Oral Contraceptive Pill in Premature Ovarian Failure: A Randomized Controlled Trial of the Effects on Bone Mineral Density via openalex
- Physiological sex steroid replacement in premature ovarian failure: randomized crossover trial of effect on uterine volume, endometrial thickness and blood flow, compared with a standard regimen via openalex
- W1927817986 via openalex
- W1969602994 via openalex
- W1970499787 via openalex
- W1972166926 via openalex
- W1973237319 via openalex
- W1973588053 via openalex
- W1974083205 via openalex
- W1987238486 via openalex
- W2010197434 via openalex
- W2016335645 via openalex
- W2022031382 via openalex
- W2023310799 via openalex
- W2027439763 via openalex
- W2028518786 via openalex
- W2030997633 via openalex
- W2039856020 via openalex
- W2054122547 via openalex
- W2057474809 via openalex
- W2064207575 via openalex
- W2067214224 via openalex
- W2079089903 via openalex
- W2079327627 via openalex
- W2101802759 via openalex
- W2104231345 via openalex
- W2104874274 via openalex
- W2105557571 via openalex
- W2109299391 via openalex
- W2112322536 via openalex
- W2118486832 via openalex
- W2119691301 via openalex
- W2120592625 via openalex
- W2126606606 via openalex
- W2129411543 via openalex
- W2130013671 via openalex
- W2137272179 via openalex
- W2141633927 via openalex
- W2154087703 via openalex
- W2157691983 via openalex
- W2161226706 via openalex
- W2170664803 via openalex
- W2254016199 via openalex
- W2272134694 via openalex
- W2327819345 via openalex
- W2398382881 via openalex
- W2409789623 via openalex
- W2559178581 via openalex
- W2788418136 via openalex
- W2794655584 via openalex
- W2807896894 via openalex
- W2892286528 via openalex
- W2909075990 via openalex
- W2912691889 via openalex
- W3012580829 via openalex
- W205608782 via openalex
- W4253262023 via openalex
- W1910353890 via openalex
- W1917209917 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-10-01T06:38:16.588661+00:00
License: CC0
· commercial use OK